Biosimilars in inflammatory bowel disease.
Monash Health, Clayton, VIC gregory.moore@monash.edu.
Gregory T
GT
Moore
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D059451:Biosimilar Pharmaceuticals / Q000191:economics* / Q000627:therapeutic use*; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic
D000911:Antibodies, Monoclonal; D059451:Biosimilar Pharmaceuticals